INTECH INVESTMENT MANAGEMENT LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1086318 WEST PALM BEACH, FL

Position in PTGX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$2,948,784

+$1,577,952 QoQ

Shares Held

24,056

+85.0% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#128

of 343 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $203,460,728 across 193 Biotechnology names. PTGX ranks #13 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	298,883	$16,262,224
2	INCY	Incyte Corp	141,278	$16,015,273
3	REGN	Regeneron Pharmaceuticals, Inc.	22,260	$13,879,999
4	HALO	Halozyme Therapeutics, Inc.	162,292	$12,702,594
5	ALNY	Alnylam Pharmaceuticals, Inc.	36,760	$11,065,862
6	VRTX	Vertex Pharmaceuticals Inc / Ma	20,520	$10,192,899
7	JAZZ	Jazz Pharmaceuticals plc	37,384	$9,008,422
8	TGTX	Tg Therapeutics, Inc.	124,646	$6,848,051

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,948,784	24,056	+85.0%	Shares	Sole	2026-08-10
2026-03-31	$1,370,832	13,006	-42.2%	Shares	Sole	2026-05-08
2025-12-31	$1,963,839	22,485	+3.9%	Shares	Sole	2026-02-10
2025-09-30	$1,437,744	21,643	-36.3%	Shares	Sole	2025-11-12
2025-06-30	$1,876,582	33,953	+9.6%	Shares	Sole	2025-08-08
2025-03-31	$1,498,289	30,982	-1.6%	Shares	Sole	2025-05-20
2024-12-31	$1,215,128	31,480	+64.6%	Shares	Sole	2025-02-11
2024-09-30	$860,760	19,128	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.